Solé, Laura http://orcid.org/0000-0002-3195-0565
Lobo-Jarne, Teresa
Álvarez-Villanueva, Daniel http://orcid.org/0000-0003-2585-622X
Alonso-Marañón, Josune
Guillén, Yolanda
Guix, Marta http://orcid.org/0000-0002-2143-0697
Sangrador, Irene
Rozalén, Catalina
Vert, Anna
Barbachano, Antonio http://orcid.org/0000-0002-1248-5143
Lop, Joan
Salido, Marta
Bellosillo, Beatriz http://orcid.org/0000-0002-5335-2726
García-Romero, Raquel
Garrido, Marta
González, Jessica
Martínez-Iniesta, María
López-Arribillaga, Erika http://orcid.org/0000-0002-9451-6635
Salazar, Ramón
Montagut, Clara
Torres, Ferrán http://orcid.org/0000-0002-7355-7913
Iglesias, Mar
Celià-Terrassa, Toni http://orcid.org/0000-0002-0615-8744
Muñoz, Alberto
Villanueva, Alberto http://orcid.org/0000-0001-5164-0006
Bigas, Anna http://orcid.org/0000-0003-4801-6899
Espinosa, Lluís http://orcid.org/0000-0002-2897-4099
Article History
Received: 30 March 2021
Accepted: 29 April 2022
First Online: 23 May 2022
Competing interests
: Laura Solé, Teresa Lobo-Jarne, Marta Guix, Beatriz Bellosillo, Mar Iglesias, Anna Bigas, and Lluís Espinosa have a pending patent application entitled Genomic predictor of outcome in cancer with number PCT/EP2022/058503, related to the fetal signature as a prognostic biomarker in colorectal cancer. The authors have no additional financial interests and the remaining authors declare no competing interests.